Zimmer Biomet makes hip and knee replacements.
Zimmer Biomet Holdings, Inc. (ZBH) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 06:30 ET. Consensus EPS estimate is $1.89.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-05 | FY2026 Q2 | $2.01 | $2.07 | +3.0% | $2.18B |
| 2026-04-28 | FY2026 Q1 | $1.86 | $2.09 | +12.4% | $2.09B |
| 2026-02-10 | FY2025 Q4 | $2.38 | $2.42 | +1.7% | $2.24B |
| 2025-11-05 | FY2025 Q3 | $1.87 | $1.90 | +1.6% | $2.00B |
| 2025-08-07 | FY2025 Q2 | $1.98 | $2.07 | +4.5% | $2.08B |
| 2025-05-05 | FY2025 Q1 | $1.77 | $1.81 | +2.3% | $1.91B |
| 2025-02-06 | FY2024 Q4 | $2.30 | $2.31 | +0.4% | $2.02B |
| 2024-10-30 | FY2024 Q3 | $1.74 | $1.74 | +0.0% | $1.82B |
ZBH has beaten consensus EPS in 8 of its last 8 reported quarters.
Highlights from ZBH's Aug 5 report: EPS of $2.07 — a beat vs the $2.01 estimate (+3%); revenue of $2.18B — in line with the $2.13B consensus. Focus now shifts to procedure volumes and new products.
ZBH pays a quarterly dividend, currently yielding 0.95%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-09-30 | $0.24 | 2026-10-30 |
| 2026-06-25 | $0.24 | 2026-07-31 |
| 2026-03-31 | $0.24 | 2026-04-30 |
| 2025-12-30 | $0.24 | 2026-01-30 |
| 2025-09-30 | $0.24 | 2025-10-31 |
| 2025-06-26 | $0.24 | 2025-07-31 |